Invicta Diagnostic Limited (NSE:INVICTA)
India · Delayed Price · Currency is INR 68.00
+2.25 (3.42%)
At close: Jun 1, 2026
Invicta Diagnostic Revenue
In the fiscal year ending March 31, 2026, Invicta Diagnostic had annual revenue of 330.42M INR with 9.48% growth. Invicta Diagnostic had revenue of 79.81M in the quarter ending March 31, 2026.
Revenue
330.42M
Revenue Growth
+9.48%
P/S Ratio
2.59
Revenue / Employee
n/a
Employees
113
Market Cap
854.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 330.42M | 28.61M | 9.48% |
| Mar 31, 2025 | 301.81M | 142.83M | 89.84% |
| Mar 31, 2024 | 158.98M | 90.55M | 132.33% |
| Mar 31, 2023 | 68.43M | 39.40M | 135.74% |
| Mar 31, 2022 | 29.03M | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.29B |
| One Global Service Provider | 4.99B |
| Chandan Healthcare | 2.65B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 814.48M |
| Aspira Pathlab & Diagnostics | 249.82M |
| Clinitech Laboratory | 96.79M |
| Dr Lalchandani Labs | 43.80M |